Table 2

Baseline characteristics and long COVID in patients without any psychiatric disorder lifetime, with at least one current psychiatric disorder, with a new-onset psychiatric disorder and with a significant suicide risk

No psychiatric disorder lifetimeAt least one current psychiatric disorderNew-onset psychiatric disordersSignificant suicide risk
N=131N=36N=29N=9
Baseline characteristics
 Age (years) (m (SD))57.2 (14.0)56.2 (9.4)54.9 (9.2)56.9 (7.2)
 Women (n (%))41 (31.3) 22 (61.1)** 18 (62.1)** 6 (66.7)
 BMI (m (SD))28.0 (7.8)28.3 (4.9)28.2 (5.3)27.7 (4.3)
 ICU stay (n (%))78 (59.5) 12 (33.3)** 9 (31.0)3 (33.3)
 Intubation (n (%))40 (30.5)6 (16.7)4 (13.8)0 (0.0)
 C-PAP (n (%))35 (26.7)7 (19.4)6 (20.7)2 (22.2)
 Length of hospital stay (days) (m (SD))22.6 (16.0)19.6 (16.5)18.2 (15.6)14.7 (17.9)
Long COVID complaints
 Number of long COVID complaints (m (SD))1.35 (1.48) 2.47 (1.30)*** 2.41 (1.32)** 2.67 (1.32)*
 Fatigue (n (%))50 (40.7)) 23 (63.9)** 19 (65.5)* 6 (66.7)
 Respiratory complaints (n (%))49 (37.4) 25 (69.4)** 19 (65.5)* 7 (77.8)*
 Cognitive complaints (n (%))23 (17.6) 17 (47.2)** 14 (48.3)** 6 (66.7)**
 Muscle weakness (n (%))14 (12.4)3 (8.3)2 (6.9)0 (0.0)
 Persistent pain (n (%))12 (10.5)4 (11.1)4 (13.8)2 (22.2)
 Headache (n (%))9 (7.9)4 (11.1)2 (6.9)1 (11.1)
 Paraesthesia (n (%))26 (22.8)8 (22.2)8 (27.6)2 (22.2)
 Persistent anosmia (n (%))10 (8.8)5 (13.9)2 (6.9)1 (11.1)
Long COVID objective criteria
 MoCA <26 (n (%))93 (66.0)22 (61.4)17 (58.6)6 (66.6)
 CT scan abnormalities86 (67.2) 14 (41.2)* 12 (41.4)* 2 (22.2)*
  • *P<0.05; **p<0.01; ***p<0.001 (bold: statistically significant (p<0.05) differences with the control group (patients without any lifetime psychiatric disorder) in bivariate analyses).

  • BMI, body mass index; C-PAP, continuous positive airway pressure; HBP, high blood pressure; ICU, intensive care unit; m, mean; MoCA, Montreal Cognitive Assessment.